You have 9 free searches left this month | for more free features.

Methylprednisolone Acetate

Showing 26 - 50 of 1,849

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cyanotic Heart Disease, Cardiopulmonary Bypass Trial in Karachi (Methylprednisolone, Saline)

Recruiting
  • Cyanotic Heart Disease
  • Cardiopulmonary Bypass
  • Karachi, Sindh, Pakistan
    Aga Khan University Hospital
Jun 30, 2023

Plantar Fascitis Trial in Minya (platelet rich plasma, MethylPREDNISolone 40 MG)

Completed
  • Plantar Fascitis
  • platelet rich plasma
  • MethylPREDNISolone 40 MG
  • Minya, Egypt
    Minya university
Jul 2, 2022

Toxic Optic Neuropathy, Treatment, Methylprednisolone Trial in Ciudad de mexico (Recombinant human erythropoietin 4,000 UI and

Recruiting
  • Toxic Optic Neuropathy
  • +3 more
  • Recombinant human erythropoietin 4,000 UI and 2,000 UI
  • Methylprednisolone succinate 500 mg
  • Ciudad de mexico, Mexico
    Jorge Cárdenas Belaunzarán
Feb 20, 2023

Methylprednisone Administration, Intranasal Administration, Intravenous Administration Trial in Mexico City (Evaluation of

Completed
  • Methylprednisone Administration
  • +3 more
  • Evaluation of bioavailability of methylprednisolone succinate administered intravenously
  • Evaluation of bioavailability of methylprednisolone succinate administered intranasally
  • Mexico City, Mexico
    Universidad Nacional Autonoma de Mexico
Dec 13, 2022

Knee Arthritis Trial in Atlanta, Tucker (Methylprednisolone, Standard of Care)

Not yet recruiting
  • Knee Arthritis
  • Atlanta, Georgia
  • +1 more
May 5, 2023

Post-COVID-19 Syndrome Trial in Berlin (Methylprednisolone)

Not yet recruiting
  • Post-COVID-19 Syndrome
  • Berlin, Germany
    Charité - Universitätsmedizin Berlin
Aug 9, 2023

Multiple Sclerosis Trial in Clermont-Ferrand (Methylprednisolone, Placebo, natalizumab (NTZ))

Recruiting
  • Multiple Sclerosis
  • Clermont-Ferrand, France
    CHU Clermont-Ferrand
Jan 5, 2023

Steroid Metabolism in Obese and Non-Obese Pediatric Patients

Completed
  • Pediatric Obesity
  • Asthma in Children
  • Durham, North Carolina
    Duke University Hospital
Jun 30, 2022

Lupus Nephritis, Remission, Safety Issues Trial in Nanjing (Methylprednisolone Injectable Suspension, Belimumab Injection,

Recruiting
  • Lupus Nephritis
  • +2 more
  • Methylprednisolone Injectable Suspension
  • +2 more
  • Nanjing, Jiangsu, China
    Jiong Zhang
May 8, 2023

Heart Block, Aortic Stenosis, Bundle-Branch Block Trial in Alicante (Methylprednisolone, Placebo)

Recruiting
  • Heart Block
  • +2 more
  • Alicante, Spain
    General University Hospital of Alicante
Oct 3, 2023

Total Knee Arthroplasty Trial in Oak Brook (Methylprednisolone, Placebo)

Recruiting
  • Total Knee Arthroplasty
  • Oak Brook, Illinois
    Rush Oak Brook Outpatient Center
Nov 15, 2022

Meniere Disease Trial (Methylprednisolon, Placebo)

Not yet recruiting
  • Meniere Disease
  • (no location specified)
May 1, 2023

Multiple Sclerosis Trial in Worldwide (Alemtuzumab GZ402673, Glatiramer acetate, Beta-Interferon)

Active, not recruiting
  • Multiple Sclerosis
  • Alemtuzumab GZ402673
  • +11 more
  • Wien, Austria
  • +20 more
Jun 16, 2022

Rhinitis, Allergic, Seasonal, Hay Fever, Pollen Allergy Trial in Lund (MethylPREDNISolone 40 Mg/mL Injectable Suspension, NaCl 9

Active, not recruiting
  • Rhinitis, Allergic, Seasonal
  • +3 more
  • MethylPREDNISolone 40 Mg/mL Injectable Suspension
  • NaCl 9 MG/ML Injectable Solution
  • Lund, Skane, Sweden
    Department of Lung-and Allergy Research
Jun 22, 2022

Methylprednisolone, Glucocorticoid, Aortic Dissection Trial (Methylprednisolone Injection)

Recruiting
  • Methylprednisolone
  • +3 more
  • Methylprednisolone Injection
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Oct 25, 2022

Migraine, Chronic Migraine, Headache Trial in London (Combined Depo-Medrone and Lidocaine, Sodium Chloride 0.9% Inj)

Completed
  • Migraine
  • Chronic Migraine, Headache
  • Combined Depo-Medrone and Lidocaine
  • Sodium Chloride 0.9% Inj
  • London, United Kingdom
    Barts Health NHS Trust
Mar 26, 2020

NSCLC Trial in Guangzhou (chest radiation, concurrent chemo, Methylprednisolone)

Terminated
  • Non-small Cell Lung Cancer
  • chest radiation
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Nov 25, 2022

Colitis Trial in Aalborg, Odense, London (Infliximab, Methylprednisolone, Prednisolone)

Not yet recruiting
  • Colitis
  • Aalborg, Denmark
  • +2 more
Jul 7, 2023

GVHD,Acute, Stem Cell Transplant Complications Trial in Chengdu (Methylprednisolone)

Recruiting
  • GVHD,Acute
  • Stem Cell Transplant Complications
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
May 9, 2022

Pneumonitis, Malignant Tumor Trial in Guangzhou (Pirfenidone, methylprednisolone, Methylprednisolone)

Recruiting
  • Pneumonitis
  • Malignant Tumor
  • Guangzhou, Guangdong, China
    Zhou Chengzhi
Mar 6, 2022

Macrophage Activation Syndrome Trial (Ruxolitinib, methylprednisolone)

Not yet recruiting
  • Macrophage Activation Syndrome
  • (no location specified)
Mar 16, 2022

Osteoarthritis, Knee, Chronic Knee Pain Trial (6% aqueous phenol, MethylPREDNISolone 40 MG, Intraarticular Knee Placebo)

Not yet recruiting
  • Osteoarthritis, Knee
  • Chronic Knee Pain
  • 6% aqueous phenol
  • +3 more
  • (no location specified)
Aug 14, 2023

Multiple Sclerosis Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Methylprednisolone,

Recruiting
  • Multiple Sclerosis
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Osteoarthritis Trial in Farmington (Ketorolac Tromethamine Injection, Methylprednisolone Acetate Injection, Hylan G-F 20)

Terminated
  • Osteoarthritis
  • Ketorolac Tromethamine Injection
  • +2 more
  • Farmington, Connecticut
    UConn Health
Feb 5, 2020

Pterygium Trial in New York (Dexamethasone Intracanalicular Insert, 0.4mg, Prednisolone Acetate 1%)

Completed
  • Pterygium
  • Dexamethasone Intracanalicular Insert, 0.4mg
  • Prednisolone Acetate 1%
  • New York, New York
    New York Eye Specialists
Apr 4, 2022